Intersect ENT

XENT NASDAQ
24.45
-0.05
-0.20%
已收盘, 16:25 06/17 EDT
开盘
24.50
昨收
24.50
最高
24.81
最低
24.09
成交量
12.42万
成交均量(3M)
43.76万
52周最高
38.25
52周最低
22.50
换手率
0.40%
市值
7.64亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Intersect ENT XENT股票价格,Intersect ENT股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology is designed to allow ENT physicians to manage patient care. The Company's commercial products are the PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. The Company is building a portfolio of products based on its drug releasing bio-absorbable implant technology that are designed to provide localized drug delivery to treat patients across the continuum of care in chronic sinusitis. The Company markets PROPEL, which is indicated for use following ethmoid sinus surgery, and PROPEL Mini, which is indicated for use following ethmoid and/or frontal sinus surgery.
展开 >

最近浏览

名称
价格
涨跌幅